Fludrocortisone, Oral

Last Modified

Tags










Abstract

Concept set to identify patients with the an exposure to the corticosteroid fludrocortisone.

Funder(s)

Provenance

Preserving Kidney Function in Children with Chronic Kidney Disease (PRESERVE)

Description

This medication concept set includes oral fludrocortisone. No combinations are included. This code list was generated by taking all descendants from the SCDG drug level for oral fludrocortisone. The codeset was reviewed by the PRESERVE BPZ workgroup led by Mark Mitsnefes. This codeset was created as part of the inclusion/exclusion criteria for the cohort of patients for the development and evaluation of EHR-based pediatric blood pressure Z-scores. One of the exclusion criteria was any exposure to an oral form of the corticosteroid fludrocortisone. This medication concept set contains only RxNorm and RxNorm Extension vocabularies.

Data Source

Related Phenotype

Related Person

Related Study

Preserving Kidney Function in Children with Chronic Kidney Disease (PRESERVE)
Children's Hospital of Philadelphia
Study intended to inform shared decision-making regarding blood pressure management for pediatric chronic kidney disease (CKD).
Derivation of Pediatric Blood Pressure References from Electronic Health Records
Cincinnati Children's Hospital Medical Center; Children's Hospital of Philadelphia
Study to examine the feasibility of using “real-world” office BP data obtained from electronic health records (EHR) to generate age-, sex- and height-specific BP percentiles for children.

Related Concept Set

Related Publications

Mitsnefes MM, Maltenfort M, Denburg MR, Flynn JT, Schuchard J, et al. November 2023. “Derivation of paediatric blood pressure percentiles from electronic health records.” EBioMedicine. 98:104885.
DOI: 10.1016/j.ebiom.2023.104885

Creative Commons license

Except where otherwised noted, this item's license is described as a CC-BY Attribution 4.0 License.